Aimmune Therapeutics, Inc.
10 drugs in NADAC|0 Generic,10 Brand
Aimmune Therapeutics, Inc. lists 10 NDCs in the CMS NADAC file (0 generic, 10 brand), at an average NADAC of $8.58 per unit, with a week-over-week move of +0.0% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
10
0G / 10B
Avg Price / Unit
$8.5787
$2.12 – $24.32
Avg 7d Change
+0.04%
Across 8 drugs with changes
7d Activity
of 10 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
pancrelipase lipase, pancrelipase protease, pancrelipase amylase market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Aimmune Therapeutics, Inc. make?
Aimmune Therapeutics, Inc. lists 10 NDCs in the CMS NADAC file — 0 generic and 10 brand products.
What is the average price of Aimmune Therapeutics, Inc. drugs?
The average NADAC across Aimmune Therapeutics, Inc.'s portfolio is $8.5787 per unit, ranging from $2.1164 to $24.3185.
Has Aimmune Therapeutics, Inc. had any drug recalls?
No FDA enforcement recalls are matched to Aimmune Therapeutics, Inc. in the openFDA feed.
How has Aimmune Therapeutics, Inc.'s pricing changed recently?
Over the past 7 days, 7 Aimmune Therapeutics, Inc. products rose and 1 fell, with a portfolio-wide average change of +0.0%.